Humacyte, Inc. Warrant (HUMAW)
Since Aug 12, 2022, Humacyte, Inc. Warrant (HUMAW) has reported earnings 15 times. On average the shares move ±3.97% post-earnings, with a positive reaction 93.3% of the time. Its largest post-earnings gain was +12% (Aug 12, 2022) and its largest decline was -38.95% (Aug 11, 2025). The next earnings report is predicted for 2026-08-12 (high confidence).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
15
Avg Abs. Movement
±3.97%
Positive %
93.3%
Negative %
6.7%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | ☀ PRE | $0.09 | $0.09 | $0.09 | 0 | +0% | open_in_new |
| Nov 12, 2025 | ☀ PRE | $0.29 | $0.29 | $0.29 | 0 | +0% | open_in_new |
| Aug 11, 2025 | ☀ PRE | $0.27 | $0.27 | $0.27 | 154 | -38.95% | open_in_new |
| May 13, 2025 | ☀ PRE | $0.30 | $0.30 | $0.30 | 0 | +0% | open_in_new |
| Mar 28, 2025 | ☀ PRE | $0.51 | $0.51 | $0.51 | 0 | +0% | open_in_new |
| Nov 08, 2024 | ☀ PRE | $2.09 | $2.09 | $2.09 | 100 | +5.56% | open_in_new |
| Aug 13, 2024 | ☀ PRE | $2.43 | $2.43 | $2.41 | 250 | +2.99% | open_in_new |
| May 10, 2024 | ☀ PRE | $0.61 | $0.61 | $0.61 | 0 | +0% | open_in_new |
| Mar 22, 2024 | ☀ PRE | $0.74 | $0.74 | $0.74 | 0 | +0% | open_in_new |
| Nov 09, 2023 | ☽ POST | $0.48 | $0.48 | $0.48 | 0 | +0% | open_in_new |
| Aug 14, 2023 | ☀ PRE | $0.67 | $0.67 | $0.67 | 0 | +0% | open_in_new |
| May 12, 2023 | ☀ PRE | $0.48 | $0.48 | $0.48 | 0 | +0% | open_in_new |
| Mar 24, 2023 | ☀ PRE | $0.48 | $0.48 | $0.48 | 0 | +0% | open_in_new |
| Nov 10, 2022 | ☀ PRE | $1.06 | $1.06 | $1.06 | 0 | +0% | open_in_new |
| Aug 12, 2022 | ☀ PRE | $1.12 | $1.21 | $1.12 | 1,100 | +12% | open_in_new |
Earnings Count
15
Total earnings in dataset
Avg Abs. Movement
±3.97%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 424B5 | 20260610 | open_in_new SEC.gov |
| 8-K | 20260610 | open_in_new SEC.gov |
| 8-K | 20260609 | open_in_new SEC.gov |
| 8-K | 20260605 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 144 | 20260518 | open_in_new SEC.gov |
| 144 | 20260518 | open_in_new SEC.gov |
Frequently asked about HUMAW earnings
When does Humacyte, Inc. Warrant report earnings next? expand_more
Humacyte, Inc. Warrant (HUMAW)'s next earnings date is predicted (high confidence) for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does HUMAW stock move after earnings? expand_more
Over 15 reports, HUMAW has moved an average of ±3.97% the session after earnings, closing higher 93.3% of the time.
What was HUMAW's biggest post-earnings move? expand_more
HUMAW's largest post-earnings gain on record was +12% on Aug 12, 2022, and its largest decline was -38.95% on Aug 11, 2025.
Where can I find Humacyte, Inc. Warrant's SEC filings? expand_more
All of Humacyte, Inc. Warrant's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right